Benzodiazepine receptor imaging with iomazenil SPECT in aphasic patients with cerebral infarction

Annals of Nuclear Medicine

Volumn 13, Issue 4, 1999, Pages 223-229

  Koshi, Yasuhiko ^a   Kitamura, Shin ^b   Ohyama, Masashi ^b   Komiyama, Tasuku ^b   Komaba, Yuichi ^b   Sakayori, Osamu ^b   Mishina, Masahiro ^b   Ishiwata, Akiko ^b   Terashi, Akiro ^b   Katayama, Yasuo ^b  

^a Takizawa Hospital   (Japan)

^b NONE

Author keywords

Aphasia; Benzodiazepine receptors; Cerebral blood flow; Cerebral infarction; Single photon emission Computed tomography

Indexed keywords

IOFETAMINE I 123; IOMAZENIL;

ADULT; AGED; APHASIA; ARTICLE; ATAXIC APHASIA; BLOOD RHEOLOGY; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION; CELL VIABILITY; CEREBELLUM CORTEX; CORTICAL SENSORY APHASIA; FEMALE; HUMAN; MALE; NERVE CELL LESION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR BINDING; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032824785     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164896     Document Type: Article

References (26)

1. Demeurisse G, Demol O, Derouck M, Beuckelaer R, Coekaerts M-J, Capon A. Quantitative study of the rate of recovery from aphasia due to ischemic stroke. Stroke 11: 455-458, 1980.
2. Hartman J. Measurement of early spontaneous recovery from aphasia with stroke. Ann Neurol 9: 89-91, 1981.
3. Kertesz A, McCabe P. Recovery patterns and prognosis in aphasia. Brain 100: 1-18, 1977.
4. Weiller C, Willmes K, Reiche W, Thron A, Isensee C, Buell U, et al. The case of aphasia or neglect after striatocapsular infarction. Brain 116: 1509-1525, 1993.
5. Metter EJ, Kempler D, Jackson C, Hanson WR, Mazziotta JC, Phelps ME. Cerebral glucose metabolism in Wernicke's, Broca's, and conduction aphasia. Arch Neurol 46: 27-34, 1989.
6. Heiss W-D, Kessler J, Karbe H, Fink GR, Pawlik G. Cerebral glucose metabolism as a predictor of recovery from aphasia in ischémie stroke. Arch Neurol 50: 958-964, 1993.
7. Ohyama M, Senda M, Kitamura S, Ishii K, Mishina M, Terashi A. Role of the nondominant hemisphere and undamaged area during word repetition in poststroke aphasies: a PET activation study. Stroke 27: 897-903, 1996.
8. Beer H-F, Bläuenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al. In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31: 1007-1014, 1990.
9. 125I-Ro16-0154: potential probe for SPECT brain imaging. Life Sci 47: 1535-1546, 1990.
10. Dey HM, Seibyl JP, Stubbs JB, Zoghbi SS, Baldwin RM, Smith EO, et al. Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123-iomazenil. J Nucl Med 35: 399-404, 1994.
11. Onishi Y, Yonekura Y, Tanaka F, Nishizawa S, Okazawa H, Ishizu K, et al. Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time. Eur J Nucl Med 23: 1491-1497, 1996.
12. Innis RB, Al-Tikriti MS, Zoghbi SS, Baldwin RM, Dybirska EH, Laruelle MA, et al. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med 32:1754-1761, 1991.
13. Sette G, Baron J-C, Young AR, Miyazawa H, Tillet I, Barré L, et al. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 24: 2046-2058, 1993.
14. 14C-labelled 2-deoxyglucose autoradiography and histopathological examination. Nucl Med Commun 16: 443-446, 1995.
15. Hatazawa J, Satoh T, Shimosegawa E, Okudera T, Inugami A, Ogawa T, et al. Evaluation of cerebral infarction with iodine-123-iomazenil SPECT. J Nucl Med 36: 2154-2161, 1995.
16. 123I]iomazenil and SPECT. Stroke 26: 2267-2271, 1995.
17. Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, et al. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med 39: 1348-1353, 1998.
18. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke 28: 124-132, 1997.
19. Goodglass H, Kaplan E. Test procedures and rationale: manual for the Boston diagnostic aphasia test. In The Assessment of Aphasia and Related Disorders. Philadelphia, Lea and Febiger., pp. 24-40, 1972.
20. Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 35: 2019-2030, 1994.
21. Koshi Y, Kitamura S, Komiyama T, Sakayori O, Komaba Y, Ohyama M, et al. A quantitative study of regional cerebral blood flow in patients with dementia of Alzheimer type using single photon emission computed tomography - clinical application of the IMP autoradiographic method (IMP ARG method) -. KAKU IGAKU (Jpn J Nucl Med) 33: 991-998, 1996.
22. Benson DF. Aphasia and the lateralization of language. Cortex 22: 71-86, 1986.
23. Berthier ML, Starkstein SE, Leiguarda R, Ruiz A, Mayberg HS, Wagner H, et al. Transcortical aphasia: importance of the nonspeech dominant hemisphere in language repetition. Brain 114: 1409-1427, 1991.
24. Basso A, Gardelli M, Grassi MP, Mariotti M. The role of the right hemisphere in recovery from aphasia. Two case studies. Cortex 25: 555-566, 1989.
25. Poeck K, Huber W, Willmes K. Outcome of intensive language treatment in aphasia. J of Speech and Hearing Disorders 54: 471-479, 1989.
26. Kabasawa H, Matsubara M, Kamimoto K, Hibino H, Banno T, Nagai H. Effects of bifemelane hydrochloride on cerebral circulation and metabolism in patients with aphasia. Clin Ther 16:471-482, 1994.